Skip to main content
  • AACR Journals
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Radiation Oncology
      • Novel Combinations
      • Reviews
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Journals
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Cancer Therapeutics
Molecular Cancer Therapeutics
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Radiation Oncology
      • Novel Combinations
      • Reviews
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Research Articles

Selective Inhibition of Histone Deacetylases Sensitizes Malignant Cells to Death Receptor Ligands

Tabitha E. Wood, Shadi Dalili, Craig D. Simpson, Mahadeo A. Sukhai, Rose Hurren, Kika Anyiwe, Xinliang Mao, Fernando Suarez Saiz, Marcela Gronda, Yanina Eberhard, Neil MacLean, Troy Ketela, John C. Reed, Jason Moffat, Mark D. Minden, Robert A. Batey and Aaron D. Schimmer
Tabitha E. Wood
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shadi Dalili
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Craig D. Simpson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mahadeo A. Sukhai
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rose Hurren
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kika Anyiwe
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xinliang Mao
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fernando Suarez Saiz
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marcela Gronda
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yanina Eberhard
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Neil MacLean
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Troy Ketela
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John C. Reed
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jason Moffat
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark D. Minden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert A. Batey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aaron D. Schimmer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1535-7163.MCT-09-0495 Published January 2010
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Online Impact

Statistics from Altmetric.com

ARTICLE USAGE

ARTICLE USAGE: January 2010 to March 2021

AbstractFull-text HTMLPDF
Total339331462470

Cited By

Article Information

Volume 9, Issue 1, pp. 246-256

DOI 
https://doi.org/10.1158/1535-7163.MCT-09-0495
PubMed 
20053768

Published By 
American Association for Cancer Research
Print ISSN 
1535-7163
Online ISSN 
1538-8514
History 
  • Received June 8, 2009
  • Revision received October 16, 2009
  • Accepted November 20, 2009
  • Published first January 12, 2010.

Article Versions

  • Previous version (January 6, 2010 - 06:39).
  • You are viewing the most recent version of this article.
Copyright & Usage 
©2010 American Association for Cancer Research.

Author Information

  1. Tabitha E. Wood1,2,
  2. Shadi Dalili1,2,
  3. Craig D. Simpson1,
  4. Mahadeo A. Sukhai1,
  5. Rose Hurren1,
  6. Kika Anyiwe1,
  7. Xinliang Mao1,
  8. Fernando Suarez Saiz1,
  9. Marcela Gronda1,
  10. Yanina Eberhard1,
  11. Neil MacLean1,
  12. Troy Ketela3,
  13. John C. Reed4,
  14. Jason Moffat3,
  15. Mark D. Minden1,
  16. Robert A. Batey2 and
  17. Aaron D. Schimmer1
  1. Authors' Affiliations: 1Princess Margaret Hospital, Ontario Cancer Institute; 2Department of Chemistry, University of Toronto; 3Department of Molecular Genetics, Donnelly Centre for Cellular and Biomolecular Research, Toronto, Ontario, Canada and 4Burnham Institute for Medical Research, La Jolla, California
  1. Corresponding Author:
    Aaron D. Schimmer, Princess Margaret Hospital, Ontario Cancer Institute, 610 University Avenue, Toronto, Ontario, Canada M5G 2M9. Phone: 416-946-2838. E-mail: aaron.schimmer{at}utoronto.ca
View Full Text
PreviousNext
Back to top
Molecular Cancer Therapeutics: 9 (1)
January 2010
Volume 9, Issue 1
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Cancer Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Selective Inhibition of Histone Deacetylases Sensitizes Malignant Cells to Death Receptor Ligands
(Your Name) has forwarded a page to you from Molecular Cancer Therapeutics
(Your Name) thought you would be interested in this article in Molecular Cancer Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Selective Inhibition of Histone Deacetylases Sensitizes Malignant Cells to Death Receptor Ligands
Tabitha E. Wood, Shadi Dalili, Craig D. Simpson, Mahadeo A. Sukhai, Rose Hurren, Kika Anyiwe, Xinliang Mao, Fernando Suarez Saiz, Marcela Gronda, Yanina Eberhard, Neil MacLean, Troy Ketela, John C. Reed, Jason Moffat, Mark D. Minden, Robert A. Batey and Aaron D. Schimmer
Mol Cancer Ther January 1 2010 (9) (1) 246-256; DOI: 10.1158/1535-7163.MCT-09-0495

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Selective Inhibition of Histone Deacetylases Sensitizes Malignant Cells to Death Receptor Ligands
Tabitha E. Wood, Shadi Dalili, Craig D. Simpson, Mahadeo A. Sukhai, Rose Hurren, Kika Anyiwe, Xinliang Mao, Fernando Suarez Saiz, Marcela Gronda, Yanina Eberhard, Neil MacLean, Troy Ketela, John C. Reed, Jason Moffat, Mark D. Minden, Robert A. Batey and Aaron D. Schimmer
Mol Cancer Ther January 1 2010 (9) (1) 246-256; DOI: 10.1158/1535-7163.MCT-09-0495
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Disclosure of Potential Conflicts of Interest
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • PX-478 Radiosensitization in Pancreatic Cancer
  • Metronomic Gemcitabine Inhibits Pancreatic Cancer
  • p53-Deficient Cells Are More Sensitive to Plk1 Inhibitor
Show more Research Articles
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About MCT

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Molecular Cancer Therapeutics
eISSN: 1538-8514
ISSN: 1535-7163

Advertisement